Abstract
Aim. The analysis of Ukrainian normative documents concerning remedies based on nanomaterials and the study of international experience on their development, quality control and safety.Methods. Methods of information retrieval and literature data analysis have been used.Results. The analysis of the State Pharmacopoeia of Ukraine, the orders of the Ministry of Health of Ukraine and other Ukrainian normative documents concerning medicines based on nanomaterials, as well as the EU legal framework on nanotechnologies and nanomaterials has been conducted. The necessity of development and approval in Ukraine of the regulatory and legal framework for medicines based on nanomaterials has been substantiated.Conclusion. The question of expediency of working out the normative and legal base for creation of medicines on the basis of nanomaterials in Ukraine is uncontested. The first steps in this direction have already been taken, but the question is still far from the solution. The lack of regulatory requirements for production, quality control and safety of medicines with nanomaterials complicates their development and makes it impossible to introduce into production
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
